Natera's Signatera MRD Assay Gains Medicare Coverage For Multiple Cancer Types
5/6 03:31
(RTTNews) - Natera, Inc. (NTRA), a leader in cell-free DNA and precision medicine, announced that its genome-based Signatera MRD assay has secured Medicare coverage under LCD L38779....